Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
Kandzari DE, Smits PC, Love MP, Ben-Yehuda O, Banai S, Robinson SD, Jonas M, Kornowski R, Bagur R, Iniguez A, Danenberg H, Feldman R, Jauhar R, Chandna H, Parikh M, Perlman GY, Balcells M, Markham P, Ozan MO, Genereux P, Edelman ER, Leon MB, Stone GW. Kandzari DE, et al. Among authors: perlman gy. Circulation. 2017 Oct 3;136(14):1304-1314. doi: 10.1161/CIRCULATIONAHA.117.028885. Epub 2017 Aug 9. Circulation. 2017. PMID: 28794001 Free PMC article. Clinical Trial.
The EluNIRTM Ridaforolimus Eluting Coronary Stent System.
Savvoulidis P, Perlman G, Bagur R. Savvoulidis P, et al. Expert Rev Med Devices. 2019 Jan;16(1):71-76. doi: 10.1080/17434440.2018.1549986. Epub 2018 Dec 1. Expert Rev Med Devices. 2019. PMID: 30452290
Ridaforolimus eluting stent for the treatment of Japanese patients with coronary disease: 1 year outcomes of the JNIR study.
Saito S, Yamazaki S, Otsuji S, Nakamura S, Takahashi A, Kawasaki T, Hasegawa K, Kandzari DE, Ozan MO, Liu M, Perlman GY, Ben-Yehuda O. Saito S, et al. Among authors: perlman gy. Cardiovasc Interv Ther. 2021 Jul;36(3):273-280. doi: 10.1007/s12928-020-00680-4. Epub 2020 Jun 26. Cardiovasc Interv Ther. 2021. PMID: 32592082 Clinical Trial.
A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial.
Paradies V, Ben-Yehuda O, Jonas M, Banai S, Iñiguez A, Perlman GY, Kandzari DE, Stone GW, Smits PC. Paradies V, et al. Among authors: perlman gy. EuroIntervention. 2018 May 20;14(1):86-93. doi: 10.4244/EIJ-D-17-00890. EuroIntervention. 2018. PMID: 29537374 Free article. Clinical Trial.
Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.
Konigstein M, Ben-Yehuda O, Smits PC, Love MP, Banai S, Perlman GY, Golomb M, Ozan MO, Liu M, Leon MB, Stone GW, Kandzari DE. Konigstein M, et al. Among authors: perlman gy. JACC Cardiovasc Interv. 2018 Dec 24;11(24):2467-2476. doi: 10.1016/j.jcin.2018.09.033. JACC Cardiovasc Interv. 2018. PMID: 30573057 Free article. Clinical Trial.
Incidence and Predictors of Target Lesion Failure in Patients With Lesions in Small Vessels Undergoing PCI With Contemporary Drug-Eluting Stents: Insights From the BIONICS Study.
Danenberg HD, Konigstein M, Golomb M, Kandzari DE, Smits PC, Love MP, Banai S, Ozan MO, Liu M, Perlman GY, Stone GW, Ben-Yehuda O. Danenberg HD, et al. Among authors: perlman gy. Cardiovasc Revasc Med. 2021 Apr;25:1-8. doi: 10.1016/j.carrev.2020.10.018. Epub 2020 Oct 28. Cardiovasc Revasc Med. 2021. PMID: 33168433 Clinical Trial.
48 results